al
ibrari
mannoseand
fucosebas
glycomimet
synthesizeda
nd
screen
icroarray
format
againstaset
ctypel
ectin
receptor
clr
includ
dcsign
dcsignr
langerin
andd
glycomimet
ligandsa
ble
interact
ere
identifi
first
time
compar
analysiso
fb
ind
profil
allow
select
clr
probe
lectin
sugarbindingp
rotein
engag
interact
endogenousa
nd
exogenousg
lycan
interact
lectin
carbohydratesa
involv
mani
fundament
biolog
event
cell
adhesiont
oa
ntigen
recognit
intern
inflamm
qualiti
control
protein
fold
abund
class
anim
lectin
ctypel
ectin
receptor
clr
serv
ab
road
rang
function
involv
pathogen
recognit
prevent
autoimmun
contribut
immun
system
abil
identifi
carbohydratebas
pathogenassoci
molecular
pattern
pamp
damagedselfassoci
molecular
pattern
damp
take
part
signal
transduct
cell
traffick
induct
tcell
differenti
name
c
type
lectin
indic
presenc
ca
ion
carbohydr
recognit
domain
crd
ion
primari
site
carbohydr
interact
typic
coordin
two
vicin
hydroxyl
group
ugar
ring
mani
ctypel
ectin
receptor
arey
et
exploreda
nd
describ
detailw
ith
regard
crd
structur
carbohydr
bind
specif
molecular
factor
govern
interact
glycan
howev
ti
sk
nown
crd
clr
featur
evolutionarili
conserv
group
residu
coordinatet
ca
ion
determin
monosaccharid
bind
specif
clr
ag
luproasn
epn
motif
result
ap
refer
mannos
man
nacetylglucosamin
glcnac
fucos
fuc
glucos
glc
residu
w
herea
glnproasp
qpd
sequenc
lead
recognit
galactos
gal
nacetylgalactosamin
galnac
avail
data
also
suggestst
hat
extend
bind
site
clr
often
display
ah
igher
affin
towardsl
arger
glycan
tructur
thank
addit
interact
occur
vicin
primari
ca
site
thu
complex
glycans
xpose
monosaccharid
bind
clr
differ
affin
depend
access
recognit
elementa
nd
addit
featur
lectin
bind
ite
structur
studiesa
lso
demonstr
secondari
bind
site
alter
affin
specif
clr
towardsl
igand
exampl
langerin
ransmembran
clr
expressedo
nl
angerhanscel
dendriticcel
specif
intercellulara
dhesion
nonintegrin
dcsign
ac
lr
express
dendrit
cell
dc
share
imilar
primari
bind
site
similar
pecif
oligomannosid
langerin
addit
calciumindepend
sugarbind
site
bind
larg
sulfatedg
lycosamino
glycan
wherea
dcsign
given
key
role
play
lectin
biolog
system
mani
research
group
turn
attent
toward
develop
glycomimet
molecul
use
select
probesf
studi
sugarprotein
interact
andor
medicin
chemistryp
urpos
glycomimet
present
sever
advantag
drug
candid
natur
glycan
sinc
made
metabol
stabl
bioavail
possibl
morea
ctive
selectivethan
natur
oligosaccharid
previou
studi
focus
inhibit
dendrit
cell
receptor
dcsign
ac
lr
implic
viral
bacteri
infect
primari
bind
site
dcsign
crd
recogn
mannoseo
ligosaccharid
lfucos
residu
lewistyp
blood
antigen
biantennari
nglycan
termin
glcnacm
oieti
addit
druggabl
site
lectin
describ
recent
dcsignmedi
adhes
dendrit
cell
first
step
severalv
iral
infect
notabl
hiv
ebola
virus
glycomimet
antagonist
dcsign
mainli
design
startingf
rom
high
mannoseg
lycan
like
man
man
glcnac
f
igur
le
x
glcnac
type
structur
particular
p
seudodi
trimannosid
fragment
w
ere
synthes
mimic
arm
man
figur
use
multival
construct
found
block
dcsignmediatedi
nfection
activ
nanomolar
level
hiv
ebola
infect
model
notabl
bisbenzylamid
deriv
also
exhibit
strong
select
toward
dcsigna
nd
bind
langerin
aclr
share
dcsign
asimilar
set
ligandsbut
rather
spread
infect
f
acilit
hiv
erad
result
suggest
appropri
modif
structur
could
repres
gener
templat
gener
ad
ivers
librari
glycomimet
contain
one
natur
monosaccharid
lectintarget
element
andatun
unit
could
providea
ddition
function
element
interact
witht
lectin
proxim
primari
bind
site
mention
structur
deriv
mimicryo
ft
disaccharid
termin
unit
rm
man
common
disaccharid
ligand
dcsign
clr
immun
system
similar
specif
uch
dcsignr
langerin
pdb
screen
uch
al
ibrari
clr
icroarrayf
ormat
may
becom
ap
otent
toolf
glycomimet
drug
discoveri
glycan
microarray
si
ntroduc
develop
past
year
essenti
tooli
nt
character
lectin
specif
andh
ave
use
pave
way
therapeut
exploit
vital
lectinsugar
interact
herein
describet
synthesi
annoseand
fucosebas
glycomimet
librari
itso
nchip
screen
set
human
clr
led
discoveri
hit
ligandsa
ble
interact
figur
natur
dcsign
ligand
man
arm
templat
design
mimic
lfuc
containingl
e
x
blood
group
antigen
linear
fragment
mimic
man
arm
pseudomannobiosid
nd
pseudomannotriosid
pseudothiomannobiosid
two
deriv
pseudomannobiosid
design
synthesi
librari
set
bi
benzylamid
compound
previous
design
dcsign
antagonist
directli
expand
annosebas
librari
adoptingt
describ
rout
start
diacid
w
ith
small
modif
scheme
scaleup
ultigram
scale
protect
common
scaffold
e
quip
av
ersatil
azidofunction
llow
furtherd
erivat
ac
ollect
bisamid
glycomimet
librari
conceiv
specif
target
one
lectin
rather
broadli
interact
clr
contain
epn
motif
crd
therefor
requir
set
amin
select
divers
w
ith
help
chemoinformat
tool
base
commerci
availabilityl
eadlik
physicochemicalfilterswer
appliedt
oal
arg
number
amin
availablec
ommerci
collect
see
experiment
section
select
sift
exclud
structurali
ncompatibilityth
remain
structur
cluster
chemoinformat
descriptor
repres
variou
subgroup
select
base
availabilityo
veral
collect
divers
amin
select
figur
allowedu
st
op
repar
manbas
deriv
f
igur
discuss
previous
anbind
clr
expect
recogn
lfucr
esidu
well
due
overlap
carbohydratespecif
impart
epn
motif
therefor
analogyt
ot
mannobiosidem
imic
bfucosylatedl
igand
synthes
link
cyclohexan
acceptor
w
ith
appropriatelyp
rotect
fucosetrichloroacetimid
onor
oy
ield
bispnitrophenylest
w
hich
react
et
primari
secondari
amin
approacha
fford
fucbas
ligand
scheme
figur
although
azidoethyl
function
glycomimet
could
principl
immobil
directli
surfacebasedc
ycloaddit
chose
extendt
short
linker
addit
heterobifunct
spacer
prior
printingt
librari
oi
mprove
ligand
accessibilityt
setup
present
addit
advantag
allow
glycomimet
print
alongsid
existingg
lycan
librari
typic
function
aminotermin
linker
end
commerci
avail
n
bicyclo
scheme
submit
select
rapid
bioorthogon
strainpromot
azidealkyn
cycloaddit
spaac
describ
agard
et
al
yield
conjug
figur
azidoterminatedl
igand
react
quantit
overnight
reaction
product
analyz
malditofm
assess
ident
result
compound
whichw
ere
later
robot
print
termin
amino
function
onto
nhydroxysuccinimidyl
ester
nh
function
glass
slidest
od
etect
interfer
linker
lectin
bind
compound
figur
microarray
design
optim
print
paramet
slide
probedw
ith
av
arieti
recombin
fluoresc
tag
human
clr
bind
profil
record
af
luoresc
cannert
fluorescencei
ntensiti
individu
spot
relatest
ot
amount
bound
lectin
estim
rel
strength
interact
elect
set
ligand
intens
valu
microarray
analysisw
ere
comparedt
oi
c
valu
determin
pr
competit
experi
dcsign
dcsignr
comparison
allow
us
critic
evalu
rank
suggest
array
interact
studi
provid
au
seful
perspect
screen
perform
human
clr
glycan
microarray
print
previous
describ
commerci
avail
nhsester
activ
glass
slide
immobil
ligandsw
confirmedb
yi
ncubat
fluoresc
label
lectin
known
glycan
specif
p
lant
lectin
concanavalin
cona
dman
fungal
aleuria
aurantia
lectin
aal
lfuc
experi
allow
optim
spot
condit
valid
arrayi
np
articular
observ
addit
dmso
printingb
uffer
afford
homogen
fluoresc
imag
array
c
ona
found
recogn
print
manbas
glycomimet
well
control
nd
w
herea
bindingt
ot
nonmannosyl
linker
fucosebas
glycomimet
observ
see
support
inform
figur
interestingli
anyo
ft
manbas
mimic
appear
interact
cona
effici
mannosei
tself
support
hypothesi
secondari
interact
contribut
overal
affin
lectin
ligand
intens
signal
obtain
somewhat
higher
shortlink
control
w
hich
suggest
bettera
ccessibl
former
compound
array
expect
screen
array
fucosespecif
aal
result
otal
differ
interact
profil
involv
exclus
fucbas
ligand
see
support
inform
figur
si
substitut
fucos
core
appar
affect
recognit
bindingi
ntensiti
seem
largelyt
fora
compound
bind
observ
linker
control
test
lectin
dcsign
langerin
extracellular
domain
ecd
produc
previous
describ
dcsignr
ecd
cd
express
ecoli
purifi
detail
support
inform
clr
label
degre
label
estim
describ
support
inform
analysisw
perform
optim
condit
describ
result
report
figur
see
ligand
group
chemic
featur
type
monosaccharid
degre
amid
substitut
rather
number
ac
ompar
heatm
ap
four
protein
reportedi
nt
support
inform
figur
si
dcsign
ransmembran
protein
express
primarili
surfac
dendrit
cell
dermalm
ucosa
variou
antigen
present
cellso
ft
myeloid
lineag
dcsign
ad
ual
role
ac
ell
surfac
patternrecogn
receptor
ediat
tcell
activationa
ddition
anumb
pathogen
notabl
hiv
viru
known
exploit
dcsign
initi
step
host
invas
thesereason
dcsign
activ
investig
arget
discoveryo
fa
ntiadhes
antivir
therapi
potenti
role
immunoregul
lectin
recogn
highli
mannosyl
oligosaccharid
often
found
viral
bacteri
cell
surfac
four
lewistyp
blood
group
antigen
le
x
le
l
e
nd
le
b
nd
mannancap
lipoarabinomannan
phosphatidylinositolmannosid
expressedo
nm
ycobacteri
surfac
array
figur
mani
mannosyl
structur
essenti
none
bfucosyl
ligand
recogn
tetramer
dcsign
xtracellular
domain
ecd
lthough
dcsign
knownt
ob
ind
fucosyl
oligosaccharid
consist
afucosid
wherea
best
knowledg
bfucosid
explor
mannosebas
ligand
identifi
red
bar
figur
ad
origin
design
dcsign
antagonist
test
spr
inhibitor
dcsign
bind
mannosyl
bsa
spr
data
microarray
resultsi
ndicat
compound
imilar
affin
lectin
w
ith
methyl
ester
least
effect
seri
none
addit
modificationso
ft
amid
function
attempt
librari
wasf
ound
improv
previou
design
hand
low
fluorescencei
ntensiti
detect
tertiarya
mide
deriv
nd
nt
chip
observ
confirm
earli
data
previouss
pr
screen
group
indic
tertiari
amid
pseudodimannosid
scaffold
significantli
reduc
bind
affin
toward
dcsign
current
set
data
strongli
suggest
featur
reliabl
use
gener
select
dcsign
overal
data
allow
valid
microarray
result
showedt
hat
screen
techniqu
implement
robusta
nd
adequ
fast
analysi
bind
activ
dcsignrel
homologu
dcsignr
lsign
express
primarili
sinusoid
endotheli
cell
lymph
node
liver
lung
gastrointestin
tract
capillari
endotheli
cell
placenta
two
homologu
exhibit
dentiti
nucleic
acid
level
dentiti
amino
acid
sequenc
display
differ
coiledcoil
neck
domain
affect
spatial
arrangemento
f
four
crd
ar
esult
two
clr
show
differ
avid
toward
multival
ligand
similarli
dcsign
dcsignr
ap
athogen
receptor
hcv
sarscoronaviru
mycobacterium
tuberculosi
r
ecogn
influenzaaand
interact
lymphocyt
microarray
screen
result
shown
figur
mani
mannosebas
ligand
interact
protein
effectivelyt
han
mannos
nd
bind
profil
rather
similar
observ
dcsign
four
ligand
nd
shown
blue
bar
figur
w
ere
select
analysi
affin
correspond
recognition
lement
nd
dcsigna
nd
dcsignr
evalu
use
spr
inhibit
assay
measur
abil
inhibit
protein
bind
mannosyl
bovin
serum
albumin
manbsa
figur
resultss
how
ome
obviou
differ
way
ligand
classifiedb
yt
two
assay
particular
ic
valu
measur
spr
dcsign
higher
expect
base
array
profil
may
simpli
reflect
intrins
differ
physicalp
rocess
interrogatedi
nt
two
assay
nt
microarray
etup
direct
bind
tetraval
lectin
ultivalentfunction
surfacei
bserv
nt
spr
inhibit
assay
ligandsa
score
base
strength
monoval
interact
protein
astrong
dependenceofth
affini
ty
valu
measur
carbohydrateproteinc
omplex
even
influenc
observ
bind
selectivityo
flectin
physic
format
assay
note
earli
repeatedlyc
onfirmedf
variou
system
ur
data
suggest
multipl
analyt
method
need
appli
fulli
character
interact
lectin
synthet
natur
ligand
repres
addit
element
complex
discoveri
select
lectin
antagonist
howev
still
possibl
use
data
varioust
echniqu
identifi
ligand
potenti
interest
drug
discoveri
program
ascertain
structur
featur
concurt
determin
activ
selectivityw
eh
ave
obtainedh
ere
first
time
microarray
spr
data
recognit
glycomimet
ligand
dcsignr
base
elabor
thesestructur
langerinisatrimericclr
abundantli
expressedonlangerhan
cell
epidermi
lower
level
myeloid
dendrit
cell
lamina
propria
human
colon
apart
protect
role
hiv
mention
lectin
bind
pathogen
candida
saccharomyc
malassezia
furfur
nd
mycobacteriuml
epra
although
langerin
dcsign
share
mani
natural
igand
differ
found
specif
toward
fucosyl
glycan
dcsign
xhibit
ag
ood
recognit
mani
fucosebas
lewistyp
ligand
le
x
l
e
l
e
b
nd
le
well
b
hb
lood
group
antigenslangerin
bind
good
affin
blood
group
antigen
ba
nd
wherea
le
l
e
b
l
e
nd
le
x
poorli
recogn
moreov
pposit
dcsign
langerin
select
recogn
sulfat
gal
galnac
glycosaminoglycan
addit
adiverg
structur
organ
distinct
express
locat
suggestf
undament
differ
biolog
role
two
clr
microarray
assay
signal
trimer
langerin
ecd
rais
nois
level
four
ligand
three
nd
known
ligand
dcsign
figur
correspond
recognit
element
nd
previous
assess
also
langerin
use
spr
inhibit
experi
describ
found
poor
competitorso
fi
mmobilizedm
anbsa
spr
inhibit
studi
repeatedf
perform
first
time
either
could
inhibitl
angerin
bind
immobil
manbsa
millimolar
concentr
support
inform
figur
si
inhibitori
activityo
couldb
eo
bserv
spr
competit
assay
b
ut
challeng
aw
eaker
interact
use
surfacef
unction
le
bsa
ap
oor
langerin
ligand
support
inform
figur
si
experi
allow
evaluationo
fa
ni
c
valu
mmf
sharp
drop
langerin
activ
could
observ
concentrationo
ft
ligand
b
ut
data
could
fit
ab
ind
isotherm
fact
ligandsd
isplay
littl
inhibitori
activ
spr
experi
still
light
microarray
may
depend
avid
polyval
present
gener
upon
print
chip
howev
rule
stage
molecul
amid
substitu
may
interact
oncompetit
fashion
hat
ad
iffer
site
carbohydr
bind
site
ecd
dendrit
cellassoci
ctype
lectin
ap
redominantli
macrophag
monocyt
associ
clr
known
specif
mannos
ap
refer
recognit
bind
bacteria
klebsiella
pneumonia
mycobacterium
tuberculosi
fungi
candida
albican
antifung
activ
demonstr
animalmodel
upon
ligand
bind
sa
ble
promot
signal
cytokin
secret
nd
final
initi
immun
respons
bind
profil
cd
toward
glycomimet
librari
shown
observedt
hat
mannosid
appear
interactm
ore
strongli
mannos
aw
eak
binder
remark
exhibit
affin
toward
tertiari
amid
structur
nd
howcas
figur
nd
bfucosyl
ligand
bare
recogn
dcsign
figur
although
two
lectin
display
imilarp
rofil
mannosidesb
ear
secondari
amid
structur
clearli
differ
fucosid
section
strikingli
mannosidebear
tertiari
amid
group
section
suggest
possibilityo
fa
nu
npreced
select
two
clr
toward
glycomimeticc
ompound
w
hich
may
relat
differ
natur
two
bind
site
inde
xray
structur
nc
omplex
man
glcnac
recent
solv
figur
how
rd
superimpos
xray
structur
dcsign
complex
pseudodimannosid
overlay
show
ah
ighli
conserv
tertiari
structur
ad
iffer
loop
close
proxim
ca
bind
site
contain
dcsign
andh
right
ligand
figur
side
ca
ion
xray
structur
show
av
eri
shallow
surfac
line
rp
side
chain
figur
align
nd
dcsign
site
show
dcsign
bind
region
blue
confin
one
side
opposit
side
ca
ion
figur
side
chain
close
contact
cyclohexan
ring
andn
ear
amid
sidec
hain
amid
deriv
figur
correspond
loop
open
valin
residu
replac
ahistidin
posit
differ
loop
orient
sh
ighlight
figur
allow
avail
space
protein
posit
amid
side
chain
mimic
indic
curv
arrow
figur
ar
esult
lectin
may
abl
accommod
mannobiosid
mimic
larger
group
tertiari
amid
interact
crd
investig
ligand
underway
set
optim
ag
lycomimet
microarray
use
ap
rimari
screen
tool
mannosefucos
elect
ctype
lectin
ad
oublyfunction
cyclooctyn
linker
use
fast
immobil
glycomimet
structur
carri
azidetermin
side
chain
array
valid
plant
fungal
ectin
known
specif
interrog
et
four
humanc
type
lectin
csign
dcsignr
langerin
ppropriat
controlss
how
lectin
examin
far
linker
interfer
bind
process
theg
lycomimet
use
base
ac
entral
cyclohexan
scaffold
carri
either
amannoseo
rabfucos
residu
furtherd
iversifi
presenceo
fd
iffer
amid
appendag
mannos
base
glycomimet
structur
deriv
mannobiosid
naturald
isaccharid
motif
interestingli
disaccharid
ac
ommonn
atur
ligand
ctype
lectin
test
studi
w
hich
contrari
differ
strongli
abil
interact
fucosecontain
oligosaccharid
thu
screen
mannos
fucos
base
glycomimet
potenti
high
interest
search
select
ligand
fact
ppear
interactw
ith
bfucosid
array
lthough
less
effect
mannosebas
deriv
screen
also
reveal
clr
studi
differenti
respondt
ot
amid
substitu
mimic
gener
differ
bind
profil
wherea
langerin
found
bind
weakli
structur
examin
dcsign
dcsignr
display
ar
ather
good
toler
secondari
amid
substitu
pseudomannobiosid
tructur
similar
recognit
profil
mosti
nterestingli
set
mannosid
carri
tertiarya
mide
substitu
found
select
recogn
verd
csign
may
explain
known
structur
two
lectin
bind
site
fucosederivedg
lycomimeticsl
oad
chip
also
display
elect
dcsign
dcsignr
thu
screen
campaign
simultan
provid
first
discoveri
glycomimet
ligand
gave
import
indic
design
optim
affin
select
compound
dcsign
dcsignr
langerin
also
measur
spr
inhibit
experi
ligand
rankingo
btain
solut
assay
differ
quantit
infer
array
bind
profil
often
observ
studi
sugarprotein
interact
affin
bind
elect
measur
lectin
strongli
depend
format
assay
nw
ay
complic
discoveri
process
case
hand
cluster
ligand
present
array
strongli
influenc
avid
system
way
cannotb
er
eproduc
bind
inhibition
xperiment
monoval
ligand
solut
compet
immobil
glycoproteint
hu
spr
array
bind
data
hould
regard
complementaryi
nformat
describ
differ
featur
ligandlectin
interact
microarray
format
test
propos
allow
bind
profil
lectin
analyz
even
avail
minut
quantiti
si
case
nt
studi
nd
may
provid
structur
inform
use
design
multival
inhibitor
mimic
dens
ligand
present
array
surfac
character
bindingp
roperti
binder
well
structuralo
ptimiz
object
activeinvestig
laboratori
gener
chemic
purchas
sigmaaldrich
acro
organ
specif
amin
key
organ
creachim
vita
ml
ab
life
chemic
alinda
chemic
chem
bridg
enamin
bb
supplier
indic
support
inform
character
ligand
use
without
purif
reaction
solvent
dri
activ
molecular
siev
tlc
carri
use
f
tlc
plate
visual
uv
irradi
nm
stain
cerium
molibd
potassium
permangan
ninhydrin
solut
canavalia
ensiformi
lectin
cona
aleuria
aurantia
lectin
aal
purchas
vectorlab
label
alexa
fluor
nh
ester
succinimidyl
ester
thermo
fisher
scientif
human
clr
prepar
label
describ
markush
structur
use
search
compound
collect
emolecul
compound
august
molport
decemb
primari
secondari
amin
particular
nli
amin
mw
number
heavi
atom
number
rotat
bond
number
ring
undefin
stereocent
consid
amin
contain
potenti
reactiv
speci
pain
also
remov
result
compound
cluster
cluster
center
select
fingerprint
molecular
descriptor
maximum
distanc
cluster
member
ta
nimoto
reduc
compound
umber
amen
visual
inspect
f
cluster
center
select
maxim
molecular
divers
base
fingerprint
result
et
primari
amin
aliphat
aromat
secondari
amin
aliphat
aromat
visual
inspect
confirm
commerci
avail
et
compound
select
acquisit
bi
diacid
g
mmol
equiv
dissolv
dri
dmf
n
pyridin
ml
mmol
mol
equiv
ad
dropwis
solut
trifluoroacet
g
mmol
mol
equiv
ad
mixtur
reaction
stir
overnight
complet
r
f
product
toluen
e
toac
acet
acid
reaction
dilut
dichloromethan
ml
wash
twice
hcl
ml
twice
cold
satur
nahco
ml
twice
water
ml
organ
phase
dri
na
f
ilter
concentr
vacuo
obtain
crystal
wash
cool
diethyl
ether
filter
yield
pure
product
aw
hite
powder
l
fucos
mg
mmol
equiv
dissolv
ml
atmospher
benzoyl
chlorid
ml
mmol
mol
equiv
ad
dropwis
solut
start
unprotect
sugar
detect
tlc
anymor
r
f
toluen
e
toac
reaction
left
warm
room
temperatur
stir
one
major
spot
visibl
tlc
plate
r
f
tolueneetoac
upon
complet
reaction
mixtur
dilut
water
extract
ch
cl
joint
organ
phase
dri
na
f
ilter
concentr
vacuo
yield
product
aw
hite
foam
yield
q
uant
ab
condit
mall
amount
fucofuranos
form
obtain
typic
around
hnmr
addit
purif
need
next
step
ixtur
acceptor
mg
mmol
equiv
donor
mg
mmol
equiv
coevapor
toluen
three
time
powder
activ
molecular
siev
acid
wash
ad
mixtur
kept
vacuum
af
ew
hour
dissolv
dri
ch
cl
ml
solut
cool
nd
tmsotf
ml
mmol
mol
equiv
ad
mixtur
reaction
stir
rt
addit
generalp
rocedur
synthesi
bisamid
amin
coupl
caffold
mol
equiv
dissolv
dri
thf
dmf
see
support
inform
n
amin
mol
equiv
ad
solut
amin
sold
ammonium
salt
amin
low
reactiv
see
support
inform
equiv
et
nw
ere
also
ad
mixtur
stir
rt
monitor
tlc
nmr
upon
complet
solut
wash
hcl
naoh
water
support
liquid
extract
cartridg
biotag
isolut
hmn
crude
purifi
flash
chromatographi
ch
cl
gradient
methanol
ru
sed
without
purif
follow
puriti
satisfi
ebenzoyl
benzoylprotect
bisamid
mol
equiv
dissolv
distil
meoh
freshli
prepar
naom
meoh
ad
solut
mol
equiv
naom
final
concentr
substrat
complet
reaction
neutral
amberlit
hydrogen
form
ionexchang
resin
filter
concentr
vacuo
crude
purifi
direct
reversephas
flash
cromatographi
ield
pure
product
librari
character
l
igand
nd
previous
describ
varga
et
al
ligand
describ
reina
et
al
wherea
character
ligand
detail
support
inform
solut
ligand
prepar
water
necessari
complet
solubil
dmso
thermo
scientif
molecular
probe
w
ad
compound
stir
overnight
room
temperatur
equimolar
amount
n
bicyclo
bcnamin
sigma
aldrich
water
convers
spaacreact
monitor
malditof
mass
spectrometri
use
acid
dhb
matrix
mg
ml
ch
queou
tfa
ontain
n
acl
maldi
data
report
support
inform
stock
solut
conjug
water
dilut
sodium
phosphat
buffer
mm
p
ween
mso
af
inal
concentr
fe
ach
solut
place
well
sourc
plate
scienion
berlin
germani
store
nd
reus
necessaryt
hese
solut
pl
pl
spot
onto
nhsfunction
glass
slide
nexterion
slide
hschott
ag
mainz
germani
ligand
spot
differ
ligand
per
row
establish
complet
microarray
print
onto
slide
print
slide
place
h
umid
chamber
satur
nacl
solut
room
temperatur
overnight
unreact
nh
group
quench
place
slide
solut
ethanolamin
sodium
borat
buffer
mm
p
immobil
ligand
probe
solut
fluoresc
label
plant
fungal
lectin
solut
concanavalin
mgml
nd
aleuria
aurantia
lectin
mgml
w
ere
prepar
pb
contain
cacl
mgcl
nd
incub
ml
lectin
solut
appli
microarray
use
proplat
slide
modul
incub
chamber
dark
room
temperatur
slide
wash
standard
condit
pb
water
dri
argon
introduc
fluoresc
analyz
amicroarray
scanner
immobil
ligand
probe
solut
fluoresc
label
ctype
lectin
solut
dcsign
mgml
dcsignr
ecd
mgml
mgml
mgml
dilut
tb
mm
mm
nacl
ph
contain
cacl
b
sa
tween
incub
mlo
fe
ach
lectin
solut
appli
subarray
use
proplat
modul
incub
chamber
microarray
incub
gentl
shake
overnight
dark
slide
wash
use
tb
contain
cacl
water
rie
argon
fluoresc
analyz
amicroarray
scanner
dcsign
extracellular
domain
dcsign
ecd
langerin
extracellular
domain
langerin
ecd
construct
produc
purifi
previous
describ
dcsignr
ecd
ecd
express
e
coli
lb
medium
supplement
mgml
kanamycin
express
induc
addit
isopropyl
iptg
cultur
reach
nm
maintain
protein
express
cytoplasm
inclus
bodi
cell
harvest
centrifug
ga
pellet
resuspend
ml
olut
contain
mm
nacl
mm
trishcl
ph
nd
one
antiproteas
mixtur
tablet
complet
edtaf
ree
roch
cell
disrupt
sonic
cell
debri
elimin
centrifug
gf
min
nabeckman
otort
pellet
solubil
ml
guanidinehcl
contain
mm
trishcl
ph
mm
nacl
bmercaptoethanol
mixtur
centrifug
gf
min
nd
supernat
dilut
slow
addit
stir
nacl
mm
cacl
mm
trishcl
ph
dcsignr
ecd
respectivelyt
dilut
mixtur
dialyz
ten
volum
mm
trishcl
ph
mm
nacl
cacl
buffer
three
buffer
chang
dialysi
insolubl
precipit
remov
centrifug
gf
supernat
contain
dcsignr
ecd
load
mannan
agaros
column
sigma
purif
affinityc
hromatographi
equilibr
buffer
load
dcsignr
ecd
tightli
bound
column
elut
buffer
without
cacl
supplement
edta
buffer
b
step
follow
sec
size
exclus
chromatographi
use
uperos
olumn
ge
heathcar
equilibr
buffer
fraction
analyz
sdspage
dcsignr
ecd
contain
fraction
pool
concentr
ultrafiltr
membran
amicon
supernat
contain
strep
tag
ecd
load
onto
treptrap
hp
column
ge
heathcar
unbound
protein
wash
away
buffer
ab
efor
ecd
elut
buffer
c
mm
nacl
mm
trishcl
ph
cacl
mmd
desthiobiotin
elut
fraction
analyz
sdspage
ecdcontain
fraction
pool
concentr
ultrafiltr
membran
amicon
protein
construct
check
ntermin
amino
acid
sequenc
mass
spectrometri
label
procedur
describ
support
inform
noshap
supportb
yt
italian
ministryo
fr
esearch
ap
rin
grant
prot
spanish
ministri
economi
industri
competit
grantc
nr
acknowledg
hmr
analys
obtain
unitech
cospect
platform
univers
milan
human
clr
ecd
product
work
use
multistepp
rotein
purif
platform
spr
platform
fort
competit
test
grenobl
instruct
center
isbg
u
ms
cnrsceaujfembl
w
ith
support
frisbi
gral
within
grenobl
partnership
structuralb
iologyf
fa
lso
acknowledg
support
french
anr
glyco
alp
